Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

Daewoong Pharmaceutical

Status: Unknown

Conditions: CT Scanning Patients

Treatments: Drug: Other: Not applicable-observational study

Study type: Observational

Funder types: Industry

Identifiers

NCT02946450

DW_IOH001

Details and patient eligibility

About

The purpose of this study is to assess safety of Omnipure inj. (lohexol) contrast media in CT scanning patients

Enrollment: 3,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• subjects in need of CT scanning
• subjects who signed up informed consent

Exclusion criteria

• Known allergy or hypersensitivity to the study medication, ingredient of the medication, and Iodine type medication
• severe renal insufficiency patients
• severe hypothyroidism
• severe local infection or bacteremia

Trial design

3,000 participants in 1 patient group

Not applicable-observational study

Description:

Not applicable-observational study

Treatment:

Drug: Other: Not applicable-observational study